October 21, 2011 -- The SFDA has released a consise summary of its registration approvals last year, showing, to nobody’s surprise, that China’s pharmaceutical scene is active -- the number of approvals numbered exactly 1,000. To make the data more useful, we have broken it down using various metrics. showing, for example, the totals by type of drug (chemical, TCM, biologic) and a comparison with 2009; the number of clinical trials approved, and the number of registration applications that were submitted. All of the data is contained in the eight easy-to-read tables. More details....
